Axert

Active Ingredient(s): Almotriptan
FDA Approved: * May 7, 2001
Pharm Company: * ORTHO MCNEIL PHARM
Category: Migraine / Tension Headache

Almotriptan (trade name Axert and others) is a triptan medication discovered and developed by Almirall for the treatment of heavy migraine headache. It was patented in 1992 and approved for medical use in 2000.[4] Contents 1 Medical uses 1.1 Efficacy 2 Contraindications 3 Side effects 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 5 Interactions 6 Society and culture 6.1 Brand names 7 References 8 External links Medical uses Almotriptan is prescri... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Axert A
Axert 12.5 mg Oral Tablet
NDC: 0062-2085
Labeler:
Ortho-mcneil-janssen Pharmaceuticals, Inc.
Axert A
Axert 12.5 mg Oral Tablet
NDC: 50458-210
Labeler:
Janssen Pharmaceuticals, Inc.
Axert A
Axert 12.5 mg Oral Tablet
NDC: 54868-5527
Labeler:
Physicians Total Care, Inc.
Axert 6.25 mg Oral Tablet
NDC: 0062-2080
Labeler:
Ortho-mcneil-janssen Pharmaceuticals, Inc.
Axert 6.25 mg Oral Tablet
NDC: 50458-211
Labeler:
Janssen Pharmaceuticals, Inc.